SCHEMBL28836859

SCHEMBL28836859

Cn1cc(C(F)(F)F)c(-c2ccc(Cl)nc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
CHRNB2 P17787 2/20 0.38
CHRNA4 P43681 2/20 0.38
PIK3CD O00329 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KCNH2 Q12809 2/20 0.37
DYRK1A Q13627 1/20 0.37
DYRK2 Q92630 1/20 0.37
ALDH1A1 P00352 1/20 0.36
RPS6KB1 P23443 1/20 0.36
CYP2A6 P11509 1/20 0.36
COMT P21964 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
NOTUM Q6P988 1/20 0.33
MAPK13 O15264 1/20 0.33
CSNK1D P48730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15885979 0.76 CHRNB2 (0.41) CHRNB2CHRNA4PIK3CDMEN1KMT2A
SCHEMBL27894903 0.76 NTRK1 (0.46) KMT2AALDH1A1MAPK13CSNK1DCSNK1E
SCHEMBL8108697 0.75 SLC34A1 (0.38) AKR1C3AKR1C2CHRNB2CHRNA4PIK3CD
SCHEMBL31626630 0.73 SMN1; SMN2 (0.46) CHRNB2CHRNA4PIK3CDMEN1KMT2A
SCHEMBL8110495 0.72 KCNH2 (0.40) CHRNB2CHRNA4PIK3CDMEN1KMT2A
SCHEMBL6430247 0.72 CYP2A6 (0.49) CYP2A6
SCHEMBL28177579 0.69 LRRK2 (0.37) KCNH2NPC1RAB9A
SCHEMBL22165900 0.69 MEN1 (0.46) MEN1KMT2A
SCHEMBL29429387 0.69 MEN1 (0.46) MEN1KMT2A
SCHEMBL8108308 0.69 MAPT (0.44) AKR1C3AKR1C2CHRNB2CHRNA4PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106317056-A Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof 赛诺菲 2017-01-11 CN disclosed